Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
30.99
+1.26 (4.24%)
Mar 14, 2025, 11:33 AM EDT - Market open

Viking Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Net Income
-109.96-85.9-68.87-54.99-39.5
Upgrade
Depreciation & Amortization
0.350.290.290.30.28
Upgrade
Other Amortization
0.090.090.060.020.11
Upgrade
Loss (Gain) From Sale of Investments
-17.38-8.21.223.913.77
Upgrade
Stock-Based Compensation
29.7116.758.676.15.82
Upgrade
Other Operating Activities
0.040.040.040.010.03
Upgrade
Change in Accounts Payable
2.3-1.027.09-2.541.56
Upgrade
Change in Other Net Operating Assets
7.064.573.1-0.386.16
Upgrade
Operating Cash Flow
-87.79-73.38-48.4-47.59-21.78
Upgrade
Investment in Securities
-553.37-179.0954.7537.9641.57
Upgrade
Investing Cash Flow
-553.37-179.0954.7537.9641.57
Upgrade
Issuance of Common Stock
654.57278.512.517.631.27
Upgrade
Repurchase of Common Stock
-42.1-7.12-8.33-0.71-0.3
Upgrade
Other Financing Activities
---0.02-0.05-0.03
Upgrade
Financing Cash Flow
612.46271.384.166.880.95
Upgrade
Foreign Exchange Rate Adjustments
-0.15-0.03-0.26--
Upgrade
Net Cash Flow
-28.8418.8810.26-2.7520.74
Upgrade
Free Cash Flow
-87.79-73.38-48.4-47.59-21.78
Upgrade
Free Cash Flow Per Share
-0.81-0.78-0.63-0.62-0.30
Upgrade
Levered Free Cash Flow
-55.58-42.36-25.22-32.16-15.06
Upgrade
Unlevered Free Cash Flow
-55.61-42.4-25.24-32.16-15.1
Upgrade
Change in Net Working Capital
-8.66-3.58-9.763.76-5.47
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.